Crowd at large AMA meeting listening to a speaker
·
5 MIN READ

AMA: Eliminate burdens for controlled substances’ e-prescribing

Delegates also push for effective opioid-use disorder in jails and prisons and emergency naloxone in public settings.

Interim Meeting
·
4 MIN READ

At Brown, syllabus covers treating opioid-use disorder

A program at the Warren Alpert Medical School of Brown University is creating physicians equipped to treat opioid-use disorder as residents.

Overdose Epidemic
·
2 MIN READ

Report shows inconsistent coverage in substance use disorder treatment

A new report from the Addiction Solutions Campaign reveals significant challenges that patients face when seeking treatment for a substance use disorder

Press Releases
·
5 MIN READ

May 4, 2017: State Advocacy Update

AMA Opioid Task Force report, Wisconsin seeks novel changes to Medicaid program and more in the latest state and local advocacy efforts.

Advocacy Update
·
4 MIN READ

April 6, 2017: State Advocacy Update

Medicaid expansion vetoed in Kansas and reauthorized in Arkansas and more in AMA's state and local advocacy efforts.

Advocacy Update
·
3 MIN READ

Feb. 23, 2017: State Advocacy Update

Prior authorization for treatment of substance use disorders, Massachusetts gun safety discussions and more in AMA's latest state and local advocacy efforts.

Advocacy Update
·
4 MIN READ

Feb. 9, 2017: State Advocacy Update

Drug testing appropriateness document, Rhode Island opioid educational toolbox and more in the latest of AMA's state and local advocacy efforts.

Advocacy Update
Diagram of simplifying path to prior authorization
·
3 MIN READ

AGs called on to help stop prior authorization for MAT

National Association of Attorneys General urged to follow New York Attorney General’s lead and stop prior authorization on medication-assisted treatment (MAT) across the nation.

Sustainability
·
5 MIN READ

Jan. 26, 2017: State Advocacy Update

Four states introduce legislation for Interstate Medical Licensure Compact, Louisiana and Utah sign standing orders for naloxone and more in AMA's latest state and local advocacy efforts.

Advocacy Update